IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartnett, M. E.
Right arrow Articles by D’Amore, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartnett, M. E.
Right arrow Articles by D’Amore, P. A.
(Investigative Ophthalmology and Visual Science. 1999;40:2945-2951.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

Release of bFGF, an Endothelial Cell Survival Factor, by Osmotic Shock

M. Elizabeth Hartnett1,2,3, Claudia M. Garcia2,3 and Patricia A. D’Amore1,2,3

1 From the Schepens Eye Research Institute, 2 Children’s Hospital of Boston, and 3 Harvard Medical School, Boston, Massachusetts.

PURPOSE. To test the effects of osmotic change on basic fibroblast growth factor (bFGF) release from cultured endothelial cells (ECs).

METHODS. Bovine aortic and bovine retinal ECs were exposed to hypoosmotic shock for 2 minutes, were allowed to recover for 15 minutes, and had bFGF release assayed. The role of bFGF in cell recovery was assessed by including neutralizing antibody against bFGF or the addition of exogenous bFGF. Cell number and viability were determined under varying conditions. Apoptosis was assessed by immunoperoxidase detection of digoxigenin-labeled DNA.

RESULTS. After shock and recovery, both ECs released significantly greater amounts of bFGF than untreated control. bFGF release after shock for 2 minutes was lower than release after shock and recovery. Bovine retinal endothelial (BRE) cell number was reduced at 48 hours after shock, recovery, and removal of released bFGF compared with cells left in the presence of released bFGF. Cell number was significantly lower when BRE cells were shocked and recovered in the presence of a neutralizing anti-bFGF antibody (P < 0.05). Exogenous bFGF reversed this effect. Apoptosis was significantly increased in BRE cells shocked and recovered or in the presence of bFGF antibody (P < 0.001).

CONCLUSIONS. bFGF is released by cultured ECs in response to osmotically induced cell injury. These results support the concept of bFGF as a "wound" hormone and survival factor for ECs. In further compromised tissue, release of bFGF in this manner may play a role in the pathogenesis of disease.




This article has been cited by other articles:


Home page
 Exp Biol MedHome page
A. C Senegaglia, L. A Barboza, B. Dallagiovanna, C. A M Aita, P. Hansen, C. L K Rebelatto, A. M Aguiar, N. I Miyague, P. Shigunov, F. Barchiki, et al.
Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?
Exp Biol Med, January 1, 2010; 235(1): 119 - 129.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology